Revvity, Inc. (NYSE: RVTY), announced a strategic agreement to commercialize an in vitro diagnostic (IVD) workflow solution for neonatal sequencing, co-developed with Element Biosciences, Inc., a life ...

“Our agile manufacturing systems, empower organizations like Akoya to reliably and efficiently scale their IVD offerings helping them meet the growing demand for precision medicine solutions.

Fapon's goal is to elevate the product portfolios of global IVD manufacturers and reduce their time-to-market through technology transfer and local manufacturing. Fapon's CLIA and biochemistry ...

Work within a regulated sequencing workflow for developing diagnostic tests and leveraging future NGS IVD tests in the pipeline ... manufactured under Current Good Manufacturing Practices (cGMPs ...

SAN DIEGO, January 13, 2025--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY), today announced a strategic agreement to commercialize an in vitro diagnostic (IVD) workflow solution for neonatal ...

Akoya Biosciences (AKYA) and Argonaut Manufacturing Services, a contract development and manufacturing organization serving the biopharma and ...

Revvity, Inc. (NYSE: RVTY), today announced a strategic agreement to commercialize an in vitro diagnostic (IVD) workflow solution for neonatal sequencing, co-developed with Element Biosciences ...